Supernus Pharma - Margin operasi SUPN

Supernus Pharma - logo grafis emiten SUPN

Core operating margins are expanding due to the outsourcing of production and logistics to external partners, while the 45.00 level indicates the status of the parameter. Trade barriers and stringent government regulation are hindering the growth of Supernus Pharmaceuticals (SUPN). To ensure stability, the company relies on a balanced portfolio of epilepsy and ADHD treatments, which allows it to minimize niche industry risks within neuromedicine.

Supernus (SUPN): Tingkat bathi operasi saka 04.07.2022 nganti 20.11.2026

Rincian analitis lan laporan data perusahaan Supernus Pharmaceuticals (SUPN)

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:supernus.com, SUPN
Produk dadi Supernus Corp

The selection of the issuer is based on the stability of operating profit before interest and taxes, which determines the efficiency of managing core business processes. By analyzing operating profitability, the investor assesses the margin of safety for Supernus Pharmaceuticals (SUPN) during the scaling of Qelbree sales and expansion into the pediatric psychiatry segment, where the ability to generate cash flow directly confirms the viability of the diversification strategy for the CNS drug portfolio.

Pesaing Supernus Pharmaceuticals

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Catalyst Pharmaceuticals Inc (CPRX) - Margin dodolan operasi|DNLI (Denali Corp) - Margin dodolan operasi|Rentabilitas dodolan operasi harmonybiosciences.com (HRMY)|Margin dodolan operasi BHVN|Margin operasi Amylyx|Margin operasi TRVI|PRAX (Praxis Corp) - Tingkat bathi operasi|Margin operasi AVXL (anavex.com)|CBLL: Rentabilitas dodolan miturut bathi operasi|PRTA - Rentabilitas operasi|ALEC - Margin operasi|Annexon Inc. (ANNX) - Rentabilitas operasi|Margin dodolan operasi Omeros Corp|Margin dodolan operasi NGNE|ACIU: Tingkat bathi operasi|Margin dodolan operasi VYGR (Voyager Corp)|Margin dodolan operasi Neumora NMRA|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi